European Medicines Agency recommends authorisation of Vimpat syrup for patients who cannot swallow tablets

View source ↗

Summary

EMA recommends authorization of Vimpat syrup to treat epilepsy in patients who cannot swallow tablets, expanding the available formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Vimpat (lacosamide)